Research
Search entire Research Database
HomePublications

Can drug price hikes via debranding be prevented?

Research output: Contribution to journal › Article

Open Access permissions

Open

Documents

Links

DOI

Authors

Organisational units

Abstract

Steep price hikes following the debranding of off-patent medicines are becoming increasingly common in the UK, adding hundreds of millions to the NHS drugs bill. But can anything be done to prevent this?

Details

Original languageEnglish
Pages (from-to)44-46
Number of pages3
JournalPrescriber
Volume28
Issue number4
DOIs
Publication statusPublished - 30 Apr 2017
Peer-reviewedNo

Downloads statistics

No data available

View graph of relations

ID: 110171169

Related by author

  1. Response to CMA Consultation (CMA 129): Draft revised Merger Assessment Guidelines

    Research output: Other contribution

  2. Unfinished Reform of the Institutions Enforcing UK Competition Law

    Research output: Chapter in Book/Report/Conference proceeding › Chapter (peer-reviewed)

  3. Response to Financial Conduct Authority: General insurance pricing practices market study – Consultation on Handbook changes

    Research output: Other contribution

  4. Does data protection legislation increase the quality of internet services?

    Research output: Contribution to journal › Article

  5. Response to EU Commission - Consultation on a New Competition Tool

    Research output: Other contribution

Related by journal

  1. Effects of telephone counselling on mortality and adherence

    Research output: Contribution to journal › Article

© UEA. All rights reserved. University of East Anglia, Norwich Research Park, Norwich, Norfolk, NR4 7TJ, UK. Telephone: +44 (0) 1603 456161 Accessibility Legal Statements .